May 28, 2026

Trial Spotlight: Megan Baumgart Highlights the ACHIEVE Trial for Patients Aged 70+ With Advanced Non-Small Cell Lung Cancer

ACHIEVE is the first lung cancer clinical trial for older patients with metastatic NSCLC, comparing immunotherapy (pembrolizumab) with and without chemotherapy